Form ARS Amphastar Pharmaceutical For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves second OTC naloxone nasal spray, Rextovy
- The St. Regis Costa Mujeres Resort, Cancún Debuts as a Refined Enclave Between Land and Sea in Mexico
- Donors commit $24 million to advance AI leadership, faculty excellence, and student success at RIT
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
